Hyena Farm Aids Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 19 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.41 Cr
- Revenue Growth %
- Profit Growth 6.45%
- Ebitda 10.25%
- Net Worth -0.05%
- Total Assets -0.31%
About Hyena Farm Aids
Hyena Farm Aids Pvt Ltd (HFAPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2006 and has a history of 19 years. Its registered office is in Nizamabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹1.41 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kunwar Singh and Nem Devi serve as directors at the Company.
Company Details
- Location
Nizamabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01119TG2006PTC049146
- Company No.
049146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2006
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hyena Farm Aids?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunwar Singh  | Director | 15-Feb-2006 | Current |
| Nem Devi | Director | 13-Apr-2019 | Current |
Financial Performance of Hyena Farm Aids.
Hyena Farm Aids Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.45% increase in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyena Farm Aids?
Unlock access to Hyena Farm Aids's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹14.10 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 1.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2009 | Punjab National Bank | ₹2.00 M | Satisfied |
| 30 Dec 2009 | Punjab National Bank | ₹1.21 Cr | Satisfied |
How Many Employees Work at Hyena Farm Aids?
Unlock and access historical data on people associated with Hyena Farm Aids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyena Farm Aids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyena Farm Aids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
